180 related articles for article (PubMed ID: 34244109)
1. Percutaneous microwave ablation versus robot-assisted hepatectomy for early hepatocellular carcinoma: A real-world single-center study.
Ding W; Yu J; Liu F; Yu X; Cheng Z; Han Z; Liang P
Dig Liver Dis; 2022 Feb; 54(2):243-250. PubMed ID: 34244109
[TBL] [Abstract][Full Text] [Related]
2. Transarterial chemoembolization combined with microwave ablation versus microwave ablation only for Barcelona clinic liver cancer Stage B hepatocellular carcinoma: A propensity score matching study.
Li X; Chen B; An C; Cheng Z; Han Z; Liu F; Yu J; Liang P
J Cancer Res Ther; 2020 Sep; 16(5):1027-1037. PubMed ID: 33004744
[TBL] [Abstract][Full Text] [Related]
3. Repeat hepatectomy versus microwave ablation for solitary and small (≤3 cm) recurrent hepatocellular carcinoma with early or late recurrence: A propensity score matched study.
Wang WQ; Lv X; Li J; Li J; Wang JL; Yuan T; Liu JJ; Zhu RH; Huang ZY; Zhang EL
Eur J Surg Oncol; 2023 May; 49(5):1001-1008. PubMed ID: 36585301
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic efficacy of microwave coagulation versus liver resection for hepatocellular carcinoma within the Milan criteria: A propensity score matching analysis.
Feng H; Yang C; Xu F; Zhao Y; Jin T; Wei Z; Wang D; Dai C
Eur J Surg Oncol; 2022 Feb; 48(2):418-424. PubMed ID: 34509336
[TBL] [Abstract][Full Text] [Related]
5. Microwave vs radiofrequency ablation for hepatocellular carcinoma within the Milan criteria: a propensity score analysis.
Liu W; Zheng Y; He W; Zou R; Qiu J; Shen J; Yang Z; Zhang Y; Wang C; Wang Y; Zuo D; Li B; Yuan Y
Aliment Pharmacol Ther; 2018 Sep; 48(6):671-681. PubMed ID: 30063081
[TBL] [Abstract][Full Text] [Related]
6. Small single perivascular hepatocellular carcinoma: comparisons of radiofrequency ablation and microwave ablation by using propensity score analysis.
An C; Li WZ; Huang ZM; Yu XL; Han YZ; Liu FY; Wu SS; Yu J; Liang P; Huang J
Eur Radiol; 2021 Jul; 31(7):4764-4773. PubMed ID: 33399908
[TBL] [Abstract][Full Text] [Related]
7. Microwave ablation versus laparoscopic resection for hepatocellular carcinoma in patients with clinically significant portal hypertension: a propensity score-matched study of postoperative liver decompensation.
Yu H; Zhao F; Men X; Zhu H; Yan J; Liu Z; Liu Q; Feng Y; Wang L; Meng M; Zhu Q; Zhao X
Eur Radiol; 2024 May; 34(5):3226-3235. PubMed ID: 37875593
[TBL] [Abstract][Full Text] [Related]
8. Microwave ablation versus other interventions for hepatocellular carcinoma: A systematic review and meta-analysis.
Cui R; Yu J; Kuang M; Duan F; Liang P
J Cancer Res Ther; 2020; 16(2):379-386. PubMed ID: 32474527
[TBL] [Abstract][Full Text] [Related]
9. Microwave ablation versus radiofrequency ablation as bridge therapy in potentially transplantable patients with single HCC ≤ 3 cm: A propensity score-matched study.
Wang X; Yu H; Zhao F; Xu Y; Wang C; Liu K; Liu B; Zheng H; Wei Y; Wang X; Zhu Q; Huang M; Feng Y
Eur J Radiol; 2023 Jul; 164():110860. PubMed ID: 37178491
[TBL] [Abstract][Full Text] [Related]
10. Microwave ablation versus sorafenib for intermediate-Stage Hepatocellular carcinoma with transcatheter arterial chemoembolization refractoriness: a propensity score matching analysis.
Chen S; Shi M; Shen L; Qi H; Wan W; Cao F; Xie L; Wu Y; Chen G; Mo J; Zhu G; Ye D; Zhang Y; Feng Z; Xu L; Fan W
Int J Hyperthermia; 2020; 37(1):384-391. PubMed ID: 32323585
[No Abstract] [Full Text] [Related]
11. [Comparison of the effectiveness of percutaneous microwave ablation versus hepatectomy for hepatocellular carcinoma].
Sheng L; Wang Y; Jun D; Peihong W
Zhonghua Zhong Liu Za Zhi; 2015 Apr; 37(4):301-7. PubMed ID: 26462897
[TBL] [Abstract][Full Text] [Related]
12. Ultrasound-guided percutaneous microwave ablation treatment of initial recurrent hepatocellular carcinoma after hepatic resection: long-term outcomes.
Zhang TT; Luo HC; Cui X; Zhang W; Zhang LY; Chen XP; Li KY
Ultrasound Med Biol; 2015 Sep; 41(9):2391-9. PubMed ID: 26074453
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of microwave ablation versus liver resection in the treatment of hepatocellular carcinoma and liver metastases: A systematic review and meta-analysis.
Yang G; Xiong Y; Sun J; Wang G; Li W; Tang T; Li J
Int J Surg; 2020 May; 77():85-93. PubMed ID: 32173611
[TBL] [Abstract][Full Text] [Related]
14. Liver resection versus microwave ablation for hepatocellular carcinoma in ideal candidates for ablation per Barcelona Clinic Liver Cancer staging: a propensity score matching and inverse probability of treatment weighting analysis.
Tong Y; Cai R; Li JX; Chang DH; Wang LZ; Cai WW; Xiao YD
Aliment Pharmacol Ther; 2022 Dec; 56(11-12):1602-1614. PubMed ID: 36285593
[TBL] [Abstract][Full Text] [Related]
15. Comparison of microwave ablation and surgical resection for treatment of hepatocellular carcinomas conforming to Milan criteria.
Shi J; Sun Q; Wang Y; Jing X; Ding J; Yuan Q; Ren C; Shan S; Wang Y; Du Z
J Gastroenterol Hepatol; 2014; 29(7):1500-7. PubMed ID: 24628534
[TBL] [Abstract][Full Text] [Related]
16. Microwave ablation versus radiofrequency ablation for subcapsular hepatocellular carcinoma: a propensity score-matched study.
Zheng H; Liu K; Yang Y; Liu B; Zhao X; Chen Y; Feng Y; Meng M; Tan X; Zhu Q
Eur Radiol; 2022 Jul; 32(7):4657-4666. PubMed ID: 35092477
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of microwave ablation versus radiofrequency ablation for hepatocellular carcinoma: a propensity score analysis.
Suwa K; Seki T; Aoi K; Yamashina M; Murata M; Yamashiki N; Nishio A; Shimatani M; Naganuma M
Abdom Radiol (NY); 2021 Aug; 46(8):3790-3797. PubMed ID: 33675382
[TBL] [Abstract][Full Text] [Related]
18. Microwave ablation provides better survival than liver resection for hepatocellular carcinoma in patients with borderline liver function: application of ALBI score to patient selection.
Chong CCN; Lee KF; Chu CM; Chan AWH; Wong J; Chan SL; Lok HT; Fung AKY; Fong AKW; Cheung YS; Yu SCH; Johnson P; Lai PBS
HPB (Oxford); 2018 Jun; 20(6):546-554. PubMed ID: 29352659
[TBL] [Abstract][Full Text] [Related]
19. Microwave ablation versus radiofrequency ablation for perivascular hepatocellular carcinoma: a propensity score analysis.
Feng Y; Wang L; Lv H; Shi T; Xu C; Zheng H; Qi J; Zhao X; Li J; Gao Y; Qin C; Zhu Q
HPB (Oxford); 2021 Apr; 23(4):512-519. PubMed ID: 32839089
[TBL] [Abstract][Full Text] [Related]
20. Radiofrequency ablation vs. surgery for perivascular hepatocellular carcinoma: Propensity score analyses of long-term outcomes.
Lee S; Kang TW; Cha DI; Song KD; Lee MW; Rhim H; Lim HK; Sinn DH; Kim JM; Kim K
J Hepatol; 2018 Jul; 69(1):70-78. PubMed ID: 29524532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
